Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conferences in Federal Transvaginal Mesh Litigations
New York, New York (PRWEB) March 17, 2013
Transvaginal mesh lawsuits continue to move forward in the federal multidistrict litigations now underway in U.S. District Court, Southern District of West Virginia. According to court records, a joint Status Conference has been scheduled for March 21st at 10:00 a.m. in four federal transvaginal mesh litigations: In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“ MDL No. 2327”). Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committees in all of these proceedings.
“We continue to hear from women who suffered serious complications following treatment with vaginal mesh. We are pleased to see these mesh lawsuits moving forward,” Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently representing hundreds of women in transvaginal mesh lawsuits who suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to products marketed by American Medical Systems, Inc., C.R. Bard, Inc., Ethicon, Inc. and Boston Scientific Corp.
Transvaginal Mesh Litigation
The litigation surrounding transvaginal mesh has been growing since 2011, when the U.S. Food & Drug Administration (FDA) warned that there had been a five-fold increase in reports of serious complications associated with the use of transvaginal mesh. The FDA also modified its previous position on the frequency of such complications, stating in the alert that vaginal mesh injuries associated with pelvic organ prolapse repair were not rare.*
In addition to the federal transvaginal mesh litigations, consolidated proceedings are also underway in New Jersey Superior Court, Atlantic County, involving products manufactured by Johnson & Johnson’s Ethicon unit and C.R. Bard. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10). Bernstein Liebhard LLP partner, Jeffrey Grand is serving as Co-Liaison Counsel in both of these litigations. Earlier this month, the nation’s first trial involving an Ethicon mesh product concluded in the New Jersey litigation, with the jury awarding more than $11 million to the Plaintiff, including $7.76 million in punitive damages. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey (Atlantic City))
Victims of alleged vaginal mesh complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries. A wealth of information regarding transvaginal mesh lawsuits can be found at Bernstein Liebhard's website. To learn more, please call 1-877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #
Felecia L. Stern, Esq.
Bernstein Liebhard LLP